Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L. O’Connell, Kirsten Grønbæk, Maria R. Baer et al.|Clinical Cancer Research|2022Cited by 27
Phase 1/2 trial of BMS‐275291 in patients with human immunodeficiency virus‐related Kaposi sarcomaBrett T. Brinker, Jamie H. Von Roenn, Amy Chadburn et al.|Cancer|2008Cited by 15